Gorchakov A - Search Results

1

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies.

Kulemzin S, Evsyukov I, Belovezhets T, Taranin A, Gorchakov A. Kulemzin S, et al. Among authors: gorchakov a. J Pers Med. 2021 Nov 11;11(11):1182. doi: 10.3390/jpm11111182. J Pers Med. 2021. PMID: 34834534 Free PMC article. Review.

2

Engineering Chimeric Antigen Receptors.

Kulemzin SV, Kuznetsova VV, Mamonkin M, Taranin AV, Gorchakov AA. Kulemzin SV, et al. Among authors: gorchakov aa. Acta Naturae. 2017 Jan-Mar;9(1):6-14. Acta Naturae. 2017. PMID: 28461969 Free PMC article.

3

[CAR T-cell therapy: Balance of efficacy and safety].

Kulemzin SV, Kuznetsova VV, Mamonkin M, Taranin AV, Gorchakov AA. Kulemzin SV, et al. Among authors: gorchakov aa. Mol Biol (Mosk). 2017 Mar-Apr;51(2):274-287. doi: 10.7868/S0026898417020148. Mol Biol (Mosk). 2017. PMID: 28537234 Free article. Review. Russian.

4

VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells.

Kulemzin SV, Gorchakov AA, Chikaev AN, Kuznetsova VV, Volkova OY, Matvienko DA, Petukhov AV, Zaritskey AY, Taranin AV. Kulemzin SV, et al. Among authors: gorchakov aa. Oncotarget. 2018 Jan 9;9(10):9021-9029. doi: 10.18632/oncotarget.24078. eCollection 2018 Feb 6. Oncotarget. 2018. PMID: 29507671 Free PMC article.

5

Design and analysis of stably integrated reporters for inducible transgene expression in human T cells and CAR NK-cell lines.

Kulemzin SV, Matvienko DA, Sabirov AH, Sokratyan AM, Chernikova DS, Belovezhets TN, Chikaev AN, Taranin AV, Gorchakov AA. Kulemzin SV, et al. Among authors: gorchakov aa. BMC Med Genomics. 2019 Mar 13;12(Suppl 2):44. doi: 10.1186/s12920-019-0489-4. BMC Med Genomics. 2019. PMID: 30871576 Free PMC article.

6

A simple way to increase recovery of the expressed VH and VL genes in single-sorted human B cells.

Guselnikov SV, Belovezhets TN, Kulemzin SV, Gorchakov AA, Taranin AV. Guselnikov SV, et al. Among authors: gorchakov aa. Biotechniques. 2019 Oct;67(4):184-187. doi: 10.2144/btn-2019-0079. Epub 2019 Aug 14. Biotechniques. 2019. PMID: 31411041 Free article.

7

Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer.

Gorchakov AA, Kulemzin SV, Kochneva GV, Taranin AV. Gorchakov AA, et al. Eur Urol. 2020 Mar;77(3):299-308. doi: 10.1016/j.eururo.2019.08.014. Epub 2019 Aug 28. Eur Urol. 2020. PMID: 31471138 Review.

8

[Combination of Oncolytic Virotherapy and CAR T/NK Cell Therapy for the Treatment of Cancer].

Kochneva GV, Sivolobova GF, Tkacheva AV, Gorchakov AA, Kulemzin SV. Kochneva GV, et al. Among authors: gorchakov aa. Mol Biol (Mosk). 2020 Jan-Feb;54(1):3-16. doi: 10.1134/S0026893320010100. Mol Biol (Mosk). 2020. PMID: 32163385 Free article. Review. Russian.

9

VAV1-overexpressing YT cells display improved cytotoxicity against malignant cells.

Smagina AS, Kulemzin SV, Yusubalieva GM, Kedrova AG, Sanzharov AE, Ivanov YV, Matvienko DA, Kalsin VA, Gorchakov AA, Baklaushev VP, Taranin AV. Smagina AS, et al. Among authors: gorchakov aa. Biotechnol Appl Biochem. 2021 Aug;68(4):849-855. doi: 10.1002/bab.2001. Epub 2020 Aug 21. Biotechnol Appl Biochem. 2021. PMID: 32767384

10

shp-2 gene knockout upregulates CAR-driven cytotoxicity of YT NK cells.

Subrakova VG, Kulemzin SV, Belovezhets TN, Chikaev AN, Chikaev NA, Koval OA, Gorchakov AA, Taranin AV. Subrakova VG, et al. Among authors: gorchakov aa. Vavilovskii Zhurnal Genet Selektsii. 2020 Feb;24(1):80-86. doi: 10.18699/VJ20.598. Vavilovskii Zhurnal Genet Selektsii. 2020. PMID: 33659784 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page